84 related articles for article (PubMed ID: 15044816)
1. N-Acetylglucosamine- an osmotic slute for peritoneal dialysis without inducing hyperinsulinemia.
Breborowicz A; Połubińska A; Simon M; Tam P; Wu G
Blood Purif; 2004; 22(2):183-7. PubMed ID: 15044816
[TBL] [Abstract][Full Text] [Related]
2. Changes in peritoneal mesothelial cells phenotype after chronic exposure to glucose or N-acetylglucosamine.
Ciszewicz M; Wu G; Tam P; Polubinska A; Breborowicz A
Transl Res; 2007 Dec; 150(6):337-42. PubMed ID: 18022595
[TBL] [Abstract][Full Text] [Related]
3. N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats.
Breborowicz A; Połubinska A; Wu G; Tam P; Oreopoulos DG
Blood Purif; 2006; 24(3):274-81. PubMed ID: 16465047
[TBL] [Abstract][Full Text] [Related]
4. Replacement of glucose with N-acetylglucosamine in peritoneal dialysis fluid-experimental study in rats.
Breborowicz A; Pawlaczyk-Kuzlan M; Pawlaczyk K; Baum E; Tam P; Wu G
Perit Dial Int; 2001; 21 Suppl 3():S365-7. PubMed ID: 11887857
[TBL] [Abstract][Full Text] [Related]
5. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats.
Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027
[TBL] [Abstract][Full Text] [Related]
6. Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis.
Shin SK; Kamerath CD; Gilson JF; Leypoldt JK
Nephrol Dial Transplant; 2006 Oct; 21(10):2874-80. PubMed ID: 16877489
[TBL] [Abstract][Full Text] [Related]
7. Effect of N-acetylglucosamine on function of peritoneal leukocytes.
Kuzlan-Pawlaczyk M; Pawlaczyk K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Wu G; Tam P; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S365-9. PubMed ID: 10406548
[TBL] [Abstract][Full Text] [Related]
8. N-acetylglucosamine changes permeability of peritoneum during chronic peritoneal dialysis in rats.
Wu G; Wieczorowska-Tobis K; Polubinska A; Korybalska K; Filas V; Tam P; French I; Breborowicz A
Perit Dial Int; 1998; 18(2):217-24. PubMed ID: 9576372
[TBL] [Abstract][Full Text] [Related]
9. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
10. Solutes transport characteristics in peritoneal dialysis: variations in glucose and insulin serum levels.
da Silva DR; Figueiredo AE; Antonello IC; Poli de Figueiredo CE; d'Avila DO
Ren Fail; 2008; 30(2):175-9. PubMed ID: 18300117
[TBL] [Abstract][Full Text] [Related]
11. The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts.
Breborowicz A; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Wisniewska J; Tam P; French I; Wu G
Adv Perit Dial; 1998; 14():31-5. PubMed ID: 10649686
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats.
Wieczorowska-Tobis K; Korybalska K; Polubińska A; Radkowski M; Breborowicz A; Montagne A; Oreopoulos DG
Adv Perit Dial; 1997; 13():42-6. PubMed ID: 9360649
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
Zweers MM; Struijk DG; Smit W; Krediet RT
J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysis.
Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2001; 17():42-6. PubMed ID: 11510294
[TBL] [Abstract][Full Text] [Related]
15. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
Abe M; Kaizu K; Matsumoto K
Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
[TBL] [Abstract][Full Text] [Related]
16. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
17. Amphotericin B does not increase peritoneal fluid removal.
Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
Adv Perit Dial; 1998; 14():3-10. PubMed ID: 10649681
[TBL] [Abstract][Full Text] [Related]
18. [Peritoneal equilibrium test with hypertonic exchange: practical application in a peritoneal dialysis program].
Ortiz A; Marrón B; Berlanga JR; Reyero A; Gazapo R
Nefrologia; 2001; 21(4):362-9. PubMed ID: 11816512
[TBL] [Abstract][Full Text] [Related]
19. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
20. L-carnitine is an osmotic agent suitable for peritoneal dialysis.
Bonomini M; Pandolfi A; Di Liberato L; Di Silvestre S; Cnops Y; Di Tomo P; D'Arezzo M; Monaco MP; Giardinelli A; Di Pietro N; Devuyst O; Arduini A
Kidney Int; 2011 Sep; 80(6):645-54. PubMed ID: 21525850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
